<DOC>
	<DOCNO>NCT01139866</DOCNO>
	<brief_summary>This extension previous research trial test SABER™-Bupivacaine ( experimental pain-relieving medication ) . The purpose extension trial ass whether treatment SABER™-Bupivacaine SABER™-Placebo effect heal participant 's shoulder , wound , skin near scar . This trial also assess safety ( side effect ) .</brief_summary>
	<brief_title>An Extension Trial Evaluate Long-term Safety SABER™-Bupivacaine Pain Following Shoulder Surgery</brief_title>
	<detailed_description>This research trial involve available subject receive treatment DURECT Protocol C803-017 . All subject follow-up safety assessment perform . No experimental treatment give trial . Subjects , Investigators , caregiver remain blinded treatment subject receive previous trial .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Participants must provide write consent participate trial prior trial procedure understand free withdraw trial time . Participants must able read understand consent form , complete trialrelated procedure , communicate trial staff . Participants must participate DURECT Protocol C803017 receive SABER™Bupivacaine SABER™Placebo approximately 18 month enrol trial . Participants participate trial investigational drug device since participation DURECT protocol C803017 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Long-term Safety</keyword>
	<keyword>Shoulder Surgery</keyword>
	<keyword>bupivacaine</keyword>
</DOC>